3 Sputnik Products Government Should Buy Right Away

Numero Uno. The brand new Sputnik Nasal Vaccine. Both as a booster and as a 2-dose regimen. We know for a fact that different vaccines not only don’t have the same effectiveness in keeping us away from hospitals and the morgue but they are also not terribly good at preventing infection and transmission. As Israel found out even after a fourth dose of Pfizer. That’s because we have no soldiers to prevent Covid-19 from living rent-free in our noses and spreading around. But as the diagram shows – pulled from Sputnik’s Twitter handle along with the pic of how it is administered – a nasal vaccine changes all that by building a wall of immunity at the top of our airways. It would also make our vaccination campaigns a lot more efficient and provide most Mauritians with a better immune response through heterologous boosting. Plus as it’s a spray no needles are involved.

Vaccination Status Can’t Ignore Jab Longevity and Performance

While it was good strategy to have several vaccines in Mauritius last year there’s quite a bit of local data available now to narrow down our choices until better and in some cases more classic ones become available or Covid morphs into an endemic. More information is also coming from the jab manufacturers themselves. 

For example, Gamaleya, which makes the mix-and-match 2-dose Sputnik V vaccine has recommended its booster jab (Sputnik Light) 6 months after the first vaccine regimen and an annual dose thereafter. This compares very favourably with the 3-month cycle that seems to be the destination with mRNA shots like Pfizer.